John Ransom analyst RAYMOND JAMES

Currently out of the existing stock ratings of John Ransom, 274 are a BUY (93.52%), 19 are a HOLD (6.48%).

John Ransom

Work Performance Price Targets & Ratings Chart

Analyst John Ransom, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 63.29% that have a potential upside of 32.35% achieved within 289 days.

John Ransom’s has documented 552 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services, Industrials sectors.

Most recent stock forecast was given on UNH, UnitedHealth Group at 01-Apr-2026.

Wall Street Analyst John Ransom

Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for RDNT (RADNET) at 11/13/2019. The price target of $18.5 was fulfilled within 8 days with a profit of $2.69 (17.01%) receiving and performance score of 21.27.

Average potential price target upside

ACHC Acadia Healthcare Company ADUS Addus HomeCare ALHC Alignment Healthcare LLC AMED Amedisys AVAH Aveanna Healthcare Holdings CI Cigna Corp CVET Covetrus CVS CVS Health Corp DVA DaVita HealthCare Partners EHC Encompass Health Corp HCA HCA Holdings HSKA Heska OSH Oak Street Health PHR Phreesia RDNT RadNet THC Tenet Healthcare UNH UnitedHealth Group AGTI Agiliti HCAT Health Catalyst AIRS Airsculpt Technologies PINC Premier SCI Service International CANO Cano Health ACCD Accolade  CHNG Change Healthcare TRUP Trupanion GDRX Goodrx Holdings  HUM Humana WBA Walgreens Boots Alliance AME Ametek GRDN Guardian Pharmacy Services OS OneStream, Common Stock

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 03-Mar-2026

$20

$-3.96 (-16.53%)

$27

1 months 1 days ago
(03-Mar-2026)

5/17 (29.41%)

$-2.99 (-13.01%)

133

Hold Since 26-Feb-2026

$22

$-1.96 (-8.18%)

$40

1 months 9 days ago
(26-Feb-2026)

9/14 (64.29%)

$-0.29 (-1.30%)

360

Buy Since 14-Jan-2026

$28

$4.04 (16.86%)

$17

1 months 9 days ago
(26-Feb-2026)

3/15 (20%)

$5.71 (25.62%)

77

Buy Since 09-Apr-2025

$22

$-1.96 (-8.18%)

$27

1 months 12 days ago
(23-Feb-2026)

1/4 (25%)

$4.62 (26.58%)

3

Buy Since 04-Jun-2015

$15

$-8.96 (-37.40%)

$105

2 months 13 days ago
(22-Jan-2026)

19/21 (90.48%)

$-0.15 (-0.99%)

1043

Show more analysts

Please expand the browser size to see the chart

Which stock is John Ransom is most bullish on?

Potential upside of $79.98 has been obtained for CI (CIGNA CORP)

Which stock is John Ransom is most reserved on?

Potential downside of -$2.99 has been obtained for GRDN (GUARDIAN PHARMACY SERVICES)

What Year was the first public recommendation made by John Ransom?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?